
Shares of drugmaker Eli Lilly LLY.N rise 8.15% to $1,086 premarket
Co forecasts FY adj. profit per share of $33.50 to $35 vs analysts’ avg estimate of $33.23 - data compiled by LSEG
Co reports Q4 adj. profit of $7.54/share vs analysts' average estimate of $6.67/share
Co's quarterly revenue of $19.29 billion beats analysts' average expectation of $17.96 billion
Shares up ~39% in 2025